We read the recent article on approach to primary immunodeficiency
disorders (PID) [1] with interest. These disorders are under-diagnosed
in the developing world. On reviewing published Indian data on PID we
came across only 4 large series reporting a total of 386 cases [3-5].
Most common PID’s reported are disorders of immune dysregulation
followed by phagocytic disorders and predominant antibody deficiencies
[4,5]. High mortality rates of upto 51% have been reported [5].
We report here a series of 11 children (8 males)
registered in our PID clinic from January to July 2013. Eight were males
and three females. Mean age was 5.2 years (4 months-12 yrs.). Two had
X-linked agammaglobuinemia. Both are on replacement intravenous
immunoglobulin (IVIG) therapy and doing well. Third, a 12-year-old male
presented to us with severe aplastic anemia (SAA) with common variable
immunodeficiency. He underwent matched sibling donor bone marrow
transplant (BMT) for SAA. At eighty days post-transplant, he has normal
blood counts and immunoglobulin levels. Fourth child had pure red cell
aplasia with isolated IgM deficiency. He responded well to prednisolone.
Fifth child had congenital neutropenia and negative for ELANE mutation
for congenital neutropenia. His neutrophils increased only after high
dose granulocyte colony stimulating factor (60 ug/kg/day). Sixth patient
had hemophagocytic lympho histiocytosis and was managed as per HLH 2004
protocol. Two infants were diagnosed as cases of autoimmune
lymphoproliferative syndrome and are doing well on prednisolone and
mycophenolate. Two were diagnosed as case of Heme-oxygenase-1 deficiency
with auto-inflammatory syndrome. One boy was diagnosed with X-linked
severe combined immunodeficiency and underwent matched unrelated donor
BMT abroad without conditioning. Although his T-cells and NK-cells
recovered but he still has low immunoglobulin levels.
Our small series shows that improvement in survival
is possible; although, pan-India improvement would require increased
awareness among pediatricians, establishing specific centers offering
genetic diagnosis and definitive therapy like BMT.
1. Madkaikar M, Mishra A, Ghosh K. Diagnostic
approach to primary immunodeficiency disorders. Indian Pediatrics. 2013;
50: 579-586.
2. Verma S, Sharma PK, Sivanandan S, Rana N, Saini S,
Lodha R, et al. Spectrum of primary immune deficiency at a
tertiary care hospital. Indian J Pediatr. 2008; 75:143-148.
3. Gupta S, Madkaikar M, Singh S, Sehgal S. Primary
immunodeficiencies in India: a perspective. Ann N YAcad Sci. 2012;
1250:73-79.
4. Madkaikar M, Mishra A, Desai M, Gupta M, Mhatre S,
Ghosh K. Comprehensive report of primary immunodeficiency disorders from
a tertiary care center in India. J Clin Immunol. 2013; 33(3):507-512.
5. Chinnabhandar V, Yadav SP, Kaul D, Verma IC,
Sachdeva A. Primary Immunodeficiency Disorders in the Developing World:
Data from A Hospital-Based Registry in India. Pediatric Hematology and
Oncology.2013 June12 (Epub ahead of print)
(doi:10.3109/08880018.2013.805346)